Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
August 1, 1994
Maternal and pediatric AIDS in the United States: the current situation and future research directions
A Blank, L M Mofenson, A Willoughby, et al.
Journal of Acquired Immune Deficiency Syndromes
|
October 1, 1993
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Bethel, J Moye, et al.
The Pediatric Infectious Disease Journal
|
June 1, 1994
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Moye, J Korelitz, et al.
JAMA
|
August 1, 1992
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Moye, J Bethel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1995
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Korelitz, S Pelton, et al.
Annals of the New York Academy of Sciences
|
October 29, 1993
Immunologic targets of HIV infection: T cells. NICHD IVIG Clinical Trial Group, and the NHLBI P2C2 Pediatric Pulmonary and Cardiac Complications of HIV Infection Study Group
W T Shearer, H M Rosenblatt, M D Schluchter, et al.
Clinical Pharmacology and Therapeutics
|
July 5, 2007
Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial
C V Fletcher, R C Brundage, T Fenton, et al.
Lancet (London, England)
|
November 25, 2003
Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
L M Mofenson, D R Harris, J Moye, et al.
The Pediatric Infectious Disease Journal
|
November 5, 1998
Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, R Yogev, J Korelitz, et al.
The Journal of Infectious Diseases
|
November 1, 1990
Measles antibody: reevaluation of protective titers
R T Chen, L E Markowitz, P Albrecht, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
August 1, 1994
Maternal and pediatric AIDS in the United States: the current situation and future research directions
A Blank, L M Mofenson, A Willoughby, et al.
Journal of Acquired Immune Deficiency Syndromes
|
October 1, 1993
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Bethel, J Moye, et al.
The Pediatric Infectious Disease Journal
|
June 1, 1994
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Moye, J Korelitz, et al.
JAMA
|
August 1, 1992
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Moye, J Bethel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 1995
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, J Korelitz, S Pelton, et al.
Annals of the New York Academy of Sciences
|
October 29, 1993
Immunologic targets of HIV infection: T cells. NICHD IVIG Clinical Trial Group, and the NHLBI P2C2 Pediatric Pulmonary and Cardiac Complications of HIV Infection Study Group
W T Shearer, H M Rosenblatt, M D Schluchter, et al.
Clinical Pharmacology and Therapeutics
|
July 5, 2007
Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial
C V Fletcher, R C Brundage, T Fenton, et al.
Lancet (London, England)
|
November 25, 2003
Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
L M Mofenson, D R Harris, J Moye, et al.
The Pediatric Infectious Disease Journal
|
November 5, 1998
Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
L M Mofenson, R Yogev, J Korelitz, et al.
The Journal of Infectious Diseases
|
November 1, 1990
Measles antibody: reevaluation of protective titers
R T Chen, L E Markowitz, P Albrecht, et al.
Page
of 5